HEATR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.927600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.441800E-01
Normal-vs-Stage2
8.899000E-01
Normal-vs-Stage3
2.263400E-01
Normal-vs-Stage4
4.711000E-01
Stage1-vs-Stage2
9.747000E-01
Stage1-vs-Stage3
2.698200E-01
Stage1-vs-Stage4
4.422800E-01
Stage2-vs-Stage3
8.080100E-02
Stage2-vs-Stage4
2.160200E-01
Stage3-vs-Stage4
2.476300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.677800E-01
Normal-vs-AfricanAmerican
7.898800E-01
Normal-vs-Asian
7.406800E-01
Caucasian-vs-AfricanAmerican
5.702100E-02
Caucasian-vs-Asian
8.556000E-01
AfricanAmerican-vs-Asian
2.351600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.852000E-01
Normal-vs-Female
6.831400E-01
Male-vs-Female
4.042200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.952400E-01
Normal-vs-Age(41-60Yrs)
8.202800E-01
Normal-vs-Age(61-80Yrs)
7.749400E-01
Normal-vs-Age(81-100Yrs)
9.336600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.144200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.880400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.932400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.655000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.382200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.578000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.214800E-01
Normal-vs-Daily Drinker
4.883400E-01
Normal-vs-Weekly Drinker
9.335000E-01
Normal-vs-Occasional Drinker
9.479000E-01
Normal-vs-Social Drinker
9.586000E-01
Non Drinker-vs-Daily Drinker
3.547800E-01
Non Drinker-vs-Weekly Drinker
6.515400E-01
Non Drinker-vs-Occasional Drinker
3.807800E-01
Non Drinker-vs-Social Drinker
5.622000E-01
Daily Drinker-vs-Weekly Drinker
2.787000E-01
Daily Drinker-vs-Occasional Drinker
1.190590E-01
Daily Drinker-vs-Social Drinker
2.123200E-01
Weekly Drinker-vs-Occasional Drinker
7.849400E-01
Weekly Drinker-vs-Social Drinker
9.431800E-01
Occasional Drinker-vs-Social Drinker
8.290200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.339200E-01
Normal-vs-Grade 2
2.021900E-02
Normal-vs-Grade 3
1.284160E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.931600E-02
Grade 1-vs-Grade 3
4.097600E-03
Grade 1-vs-Grade 4
2.339200E-01
Grade 2-vs-Grade 3
1.047250E-01
Grade 2-vs-Grade 4
2.021900E-02
Grade 3-vs-Grade 4
1.284160E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.631600E-01
Normal-vs-NonDiabetic
7.368200E-01
Diabetic-vs-NonDiabetic
6.006800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.261600E-01
Normal-vs-NoPancreatitis
7.601600E-01
Pancreatitis-vs-NoPancreatitis
5.337000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.343400E-01
Normal-vs-N1
8.151000E-01
N0-vs-N1
9.463200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.879400E-01
Normal-vs-TP53-NonMutant
8.892600E-01
TP53-Mutant-vs-TP53-NonMutant
6.541600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
